Repros Therapeutics (RPRX) Reports Q2 Loss of $0.18/Share

August 9, 2016 9:20 AM EDT
Get Alerts RPRX Hot Sheet
Trade RPRX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Repros Therapeutics (NASDAQ: RPRX) reported Q2 EPS of ($0.18), versus ($0.32) reported last year.

For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment